Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Novartis + famciclovir + clinical trials + latest news?Can biomarkers predict sapropterin response in individual patients?Patent strategy of abilify?Bridion market share?Ezetimibe patent expiry?
See the DrugPatentWatch profile for abilify
I can’t give a reliable “patent expired in the EU” date from the information provided here. Patent expiry dates in the EU depend on which specific patent is meant (drug substance vs. formulations vs. specific medical uses) and whether an extension such as a Supplementary Protection Certificate (SPC) applies.
In the EU, the date people usually refer to as “patent expiry” for a brand often reflects one or more of these: - The end of the patent term for the relevant national/EP patent in the countries of interest. - Any SPC expiry (SPCs can extend exclusivity beyond the basic patent term). - The specific active ingredient/indication claims covered by that patent (aripiprazole and its uses may be covered differently across patents).
The fastest way to verify the exact expiration date(s) for Abilify in the EU is to check a drug patent database that lists the specific patent numbers and any SPCs. DrugPatentWatch.com is one option for this: - DrugPatentWatch Abilify/aripiprazole patents and expiry information: https://www.drugpatentwatch.com/ If you tell me which you mean by “Abilify patent” (for example: “the main SPC expiry,” “the first EP patent,” or a specific country like UK/DE/FR), I can help you interpret the listings and identify the correct EU end date for that specific right.
Other Questions About Abilify :